Clinical Trial Update: SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for SDF1 plasmid therapy in peripheral artery disease; current trial status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• SDF1 plasmid (SDF-1 plasmid)

Snippet

Sponsor: Juventas Therapeutics, Inc. | Conditions: Peripheral Arterial Disease | Phase 2 | Status: UNKNOWN